about
Sample size calculation for a stepped wedge trialStepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014The association between psychological stress and miscarriage: A systematic review and meta-analysis.A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials.Probabilistic sensitivity analysis in health economics.Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data.A feasibility randomised controlled trial of extended brief intervention for alcohol misuse in adults with mild to moderate intellectual disabilities living in the community; The EBI-LD study.An educational review of the statistical issues in analysing utility data for cost-utility analysis.Bayesian regression discontinuity designs: incorporating clinical knowledge in the causal analysis of primary care data.Health Data Entanglement and artificial intelligence-based analysis: a brand new methodology to improve the effectiveness of healthcare services.Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.Economic burden of human papillomavirus-related diseases in Italy.Bayesian models for cost-effectiveness analysis in the presence of structural zero costs.Cost-effectiveness and affordability of community mobilisation through women's groups and quality improvement in health facilities (MaiKhanda trial) in MalawiMonetary costs of agitation in older adults with Alzheimer's disease in the UK: prospective cohort study.Extended brief intervention to address alcohol misuse in people with mild to moderate intellectual disabilities living in the community (EBI-ID): study protocol for a randomised controlled trial.Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study.Five questions to consider before conducting a stepped wedge trial.Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.Effectiveness of an intervention to facilitate prompt referral to memory clinics in the United Kingdom: Cluster randomised controlled trialComparison of computer-assisted planning and manual planning for depth electrode implantations in epilepsy.Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximationApproaches to the Estimation of the Local Average Treatment Effect in a Regression Discontinuity Design.Object-oriented influence diagram for cost-effectiveness analysis of influenza vaccination in the Italian elderly population.The prevalence of primary angle closure glaucoma in European derived populations: a systematic review.Spatial and spatio-temporal models with R-INLA.Spatial and spatio-temporal models with R-INLA.A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project.Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approachesUptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 months.Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.Health utilities lost and risk factors associated with HPV-induced diseases in men and women: the HPV Italian collaborative study group.Preformulated implementation intentions to promote colorectal cancer screening: a cluster-randomized trial.Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models.Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities.Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.Transparency or proper study valuation procedures missed?Correction: Economic Burden of Human Papillomavirus-Related Diseases in Italy.
P50
Q26797481-59E9BEE3-71C4-4F14-BF80-4A872D26B503Q26798053-03C2BD97-AF31-4DD3-AF18-1260EA798058Q29994805-404539C1-884D-43FA-AED2-595E53FB4FFAQ30363781-74C60A62-5477-4E42-AD84-51E8A9178C2FQ30369197-D01958A9-2EAB-45E7-B173-108A8952D446Q30407247-E5A2B30C-E0CC-4242-AC5A-B2B3EDF4E82EQ30848226-C628182A-D019-443C-90DE-5A6B0298519EQ30849075-C53B36E1-9734-4D08-A307-B8632E26409EQ30884759-98D14DA8-7D61-415F-B2E1-F23427A5F0D2Q30916484-A566BDC8-6FBB-402D-9BC7-29E3A123DA76Q31142383-4AB071AB-00CA-40DF-ACF4-5F9314550783Q33892348-10860CB8-AC04-4D08-802D-24603FDDB62FQ34490403-5FA52A2C-A6A5-4B85-9B50-F4A2D37E8CAAQ34844884-3D97C5B3-F3A6-4816-8F1A-4F0509220A19Q34986875-405D42E1-66FE-4FA3-938E-4AEF47155E81Q35179445-42FEFA4A-733D-4DFE-B2A7-6206A76B91BCQ35320405-32617E1D-3402-4C5A-84EF-B771F9F721E0Q35838225-D07063E8-1F19-4BFA-95BB-263EDB946AD3Q35961666-D8675777-160B-4DC1-8BE1-FEC0D293B61AQ36184250-7BA487AD-E690-4408-B0A8-F823D3A61BF1Q36307380-45BEB6A2-4734-4890-B578-1FA9CB7032D6Q36763163-1B4876D5-8558-43B5-8B3C-977699680B32Q37063626-56F646B6-A77B-4E40-A636-DFD0ADEB3359Q37272487-B9003167-D8BF-4860-8652-62023C6B3E42Q37418133-257070ED-AFB7-41CB-9C7C-7CAF5287A400Q37763171-ACC9D227-11F5-4F21-9A07-327388C29F3FQ38015239-BA6F1BEB-42DE-4388-988C-8D4F34BAD17DQ38088494-8930E3FE-BD1E-4B25-8A3E-139AE1943FA0Q38174621-B568DBCD-5555-4D0C-A3A9-749538C08CD2Q38379036-C16BD217-140D-4C70-8F92-2E8C2ECE19F8Q38952910-F1CB9827-4EAA-4143-BCA8-5297054261CCQ38962048-B4318843-1A2A-46BD-994E-56B2D068A7C8Q38990039-B826DF5B-3C5D-42E9-9AB5-369F28AE0B81Q39079731-F4C31E8B-F888-4133-B14B-05C23365DB48Q39312911-3363A002-F643-4523-9E83-35C4AED6DE48Q40128380-73626260-F481-49C4-ACB3-24F9EF8AF2E1Q40171568-59D1DE35-B65F-41A0-9E73-271FC50C967CQ40864384-FA6F3B8C-DB42-46D4-80F8-16E42474DD9CQ42399271-AA234904-D32B-4C1F-9940-363EB9837F4EQ42954247-38D43B77-CE38-4FC3-85B9-9BE912362F35
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gianluca Baio
@ast
Gianluca Baio
@en
Gianluca Baio
@es
Gianluca Baio
@nl
Gianluca Baio
@sl
type
label
Gianluca Baio
@ast
Gianluca Baio
@en
Gianluca Baio
@es
Gianluca Baio
@nl
Gianluca Baio
@sl
prefLabel
Gianluca Baio
@ast
Gianluca Baio
@en
Gianluca Baio
@es
Gianluca Baio
@nl
Gianluca Baio
@sl
P106
P1153
6603354734
P31
P4594
P496
0000-0003-4314-2570